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Carbohydrates have been shown to mediate or modulate a number of important events in the development of the nervous
system; however, there is little evidence that they participate directly in the development of synapses. One carbohydrate
structure that is likely to be important in synaptic development of the neuromuscular junction is the CT carbohydrate
antigen {GalNAcb1,4[NeuAca2,3]Galb1(-3GalNAc or -4GlcNAc)}. The synaptic localization of the CT antigen is due to the
presence of the terminal b1,4 GalNAc linkage, and such linkages are localized to the neuromuscular junction in many
species. Here we show that an enzyme that can create the synaptic CT structure, the CT GalNAc transferase, is also
confined to the neuromuscular junction in mice. Using transgenic mice, we show that overexpression of the CT GalNAc
transferase in extrasynaptic regions in skeletal myofibers caused as much as a 60% reduction in the diameter of adult
myofibers and an order of magnitude increase in satellite cells. Neuromuscular junctions of transgenic mice had severely
reduced numbers of secondary folds, Schwann cell processes were present in the synaptic cleft, and secondary folds were
often misaligned with active zones. In addition, multiple presynaptic specializations occurred on individual myofibers. In
addition, some normally synaptic proteins, including laminin a4, laminin a5, utrophin, and NCAM, were expressed along
extrasynaptic regions of myofibers. One of the muscle proteins that displayed increased glycosylation with the CT antigen
in the transgenic mice was a-dystroglycan. These experiments provide the first in vivo evidence that a synaptic
carbohydrate antigen has important roles in the development of the neuromuscular synapse and suggest that the CT antigen
is involved in controlling the expression of synaptic molecules. © 2002 Elsevier Science
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Synapse formation requires the precise apposition of a
large number of proteins, both in time and in space (for
review, see Sanes and Lichtman, 1999). Since most proteins
that reside within the synaptic cleft are glycoproteins, one
means of discriminating synaptic proteins from their extra-
synaptic counterparts would be the creation of a unique
synaptic “glyco-environment.” Such a specialized glycan
environment could be required for the precise alignment
and packing of the high density of proteins that occurs at
synapses, for unique synaptic cell adhesion, for synaptic
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58targeting of proteins, or to create novel synaptic signaling
mechanisms. A number of studies have implicated carbo-
hydrates in other aspects of neural development, including
cell fate, neural migration, stem cell proliferation, myelina-
tion, axon guidance, dendrite maturation, and neural sig-
naling (for reviews, see Rutishauser and Landmesser, 1996;
Yamaguchi, 2001; Muramatsu, 2000; Jessel et al., 1990;
Margolis and Margolis, 1989). Given the importance of
carbohydrates in these developmental events, it is likely
that they also have roles in synapse formation, although the
evidence in support of this notion is scarce.
Several carbohydrate structures have been implicated in
aspects of synapse formation. Changes in polysialic acid
(PSA) levels have been implicated in estrogen-induced
changes in synaptic structure in the arcuate nucleus (Hoyk
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plasticity in the hypothalamic–neurohypophysial system
(Theodosis et al., 1999), and in ectopic mossy fiber–
pyramidal cell synapse formation in the hippocampus (Seki
and Rutishauser, 1998). In addition, PSA (Eckhardt et al.,
2000), heparan sulfate (Lauri et al., 1999), and mannose
oligosaccharides (Luthi et al., 1994) can affect synaptic
plasticity paradigms such as long-term potentiation in the
hippocampus. Mannose structures have been implicated in
presynaptic vesicle aggregation in sensory neurons in the
leech (Tai and Zipser, 1998), and studies of mannose bind-
ing lectins such as concanavalin A suggest that glycans may
control the specificity of certain synaptic connections in
Aplysia (Lin and Levitan, 1987). In many of these studies,
however, it is not clear whether the effects observed are
direct effects of glycan (e.g., glycan binding to a receptor) or
whether they are a secondary consequence of more generic
alterations in membrane structure or charge. Moreover, it is
often not clear in such studies whether the carbohydrate in
question is uniquely present at synapses or whether such
localization is generally applicable to the synapses of more
than one species.
One of the keys to identifying glycans that are important
for synapse formation is to identify those structures that are
uniquely present at synapses and whose synaptic expres-
sion has been phylogenetically conserved. Demonstration
of the conservation of synaptic expression in different
species is an important clue to function for carbohydrate
structures, as carbohydrates are often receptors or corecep-
tors for bacterial or viral pathogens (Gagneux and Varki,
1999). As such, they are likely to be placed under intense
evolutionary pressure. The neuromuscular junction con-
tains such a synaptic saccharide, terminal b-linked
N-acetyl-D-galactosamine or bGalNAc (Sanes and Cheney,
1982; Scott et al., 1988). The synaptic localization of
bGalNAc in skeletal muscle is conserved in rodents, hu-
mans, chicks, frogs, fish, and birds, and is highly concen-
trated, though not exclusively so, at neuromuscular junc-
tions in lamprey and Torpedo (Scott et al., 1988). Several
bGalNAc-containing structures have been defined at the
mammalian neuromuscular junction (Martin et al.,
1999). Among these are the CT carbohydrate antigens
{GalNAcb1,4[NeuAca2,3]Galb1(-3GalNAc or -4GlcNAc)-
R}, which are defined by the CT1 and CT2 monoclonal
antibodies (Lefrancois and Bevan, 1985). In mice, these
structures are referred to as the CT antigen for their original
description in activated cytotoxic T cells (Lefrancois and
Bevan, 1985). In humans, they correspond to the Cad or Sda
blood group antigens (Conzelmann and Lefrancois, 1988).
Cad and Sda are relatively rare blood groups in humans,
although these structures are more commonly expressed in
other human tissues (Dohi et al., 1996).
The enzyme responsible for making the synaptic
b1,4GalNAc linkage on the CT antigen is the CT GalNAc
transferase (Smith and Lowe, 1994). This enzyme requires
NeuAca2,3Galb1,-R (where R is usually 4GlcNAc or 3Gal-
NAc) as a substrate and modifies glycoproteins but gener-
© 2002 Elsevier Science. Aally not glycolipids (Smith and Lowe, 1994). While it has
not been proven, the CT GalNAc transferase is most likely
not the same enzyme as the GalNAc O-phosphotransferase
activity previously described at the neuromuscular junction
(Scott et al., 1990). This enzyme migrates at a very different
molecular weight than that of the CT GalNAc transferase
and appears to have an entirely different enzymatic activity
(Balsamo et al., 1986). Here we describe the synaptic local-
ization of the CT GalNAc transferase at the neuromuscular
junction. Using ectopic expression of the transferase in the
skeletal muscles of transgenic mice, we also identify novel
functions for this type of glycosylation in muscle and
neuromuscular development and demonstrate its presence
on a-dystroglycan.
MATERIALS AND METHODS
Materials
Monoclonal antibody to desmin (DE-U-10) was obtained from
Sigma. Monoclonal antibodies to a-sarcoglycan (Ad1/20A6),
b-dystroglycan (43DAG1/8D5), utrophin (DRP3/20C5), and dystro-
phin (Dy4/6D3) were obtained from Nova Castra. Antibody to
laminin a2 (4H8-2) was obtained from Alexis Biochemicals. An
additional polyclonal antisera, DG67, was made against the
C-terminal 15 amino acids of b-dystroglycan in our laboratory and
purified against an immunogenic peptide-coupled resin. Antibody
to laminin b1 (5A2) was a gift from Dale Abrahamson (University
of Alabama, Birmingham). Antisera to ab-dystroglycan (OR12)
and antibody to a-dystroglycan (IIH6) were gifts from Kevin Camp-
bell (HHMI, University of Iowa, Iowa City). Antibody to
a-dystroglycan (VIA4-1) was purchased from Upstate Biotechnol-
ogy. Hybridomas producing antibodies against the CT antigen
(CT1, CT2) were gifts from Leo Lefrancois (University of Connecti-
cut, Storrs). Polyclonal antibodies to NCAM, laminin a4, laminin
a5, and laminin b2 were gifts from Joshua Sanes (Washington
University, St. Louis, MO). Polyclonal antibodies to the acetylcho-
line receptor epsilon chain and c-met were obtained from Santa
Cruz Biotechnology. Polyclonal antibody to acetylcholinesterase
was a gift from Palmer Taylor [University of California, San Diego
(UCSD)]. Polyclonal antibody to neuron-specific enolase was ob-
tained from Chemicon. Antibody to synaptophysin was obtained
from Boehringer Mannheim. Monoclonal antibody to a-dystro-
brevin (d32620) was obtained from BD Transduction Labs. Three
anti-peptide antibodies were raised in rabbit against peptide se-
quences encoded in the CT GalNAc transferase. CT76 was made
against KVALQYFKNHLYCST, CT77 was made against MTSSVS-
FASFRFPWLLK, and CT68 was made against KLRMKYKFQ-
DAYNQKD. Staining and blotting with CT68 are shown in Fig. 1.
These antibodies were affinity purified against the immunogenic
peptide conjugated to Affigel 10 (Bio-Rad) using standard low pH
methods (Harlow and Lane, 1988). All secondary antibodies were
purchased from Boehringer Mannheim or Zymed. Rhodamine-a-
bungarotoxin was purchased from Molecular Probes. WFA (Wist-
eria floribunda Agglutinin) agarose was purchased from EY labora-
tories. Protein G agarose was purchased from Boehringer
Mannheim. Anti-mouse IgM agarose was purchased from Jackson
Laboratories.
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For hematoxylin–eosin, myosin ATPase, and immunofluores-
cence staining of thin sections, muscles were snap frozen in liquid
nitrogen-cooled isopentane and sectioned at 6 mm on a cryostat. For
whole-mount preparations, diaphragm or intercostal muscles were
dissected and fixed in 2% paraformaldehyde with 0.1% Triton
X-100. For confocal imaging, mice were anesthetized with 1 ml/kg
nembutol, stretched, and perfused by intracardiac catheterization
with buffer (135 mM NaCl, 14 mM NaHCO3, 1.2 mM Na2HPO4, 5
mM KCl, 2 mM CaCl2, and 1 mM MgCl2) at 35°C, followed by 4%
FIG. 1. Characterization of transgenic mice expressing the CT Ga
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and fixed for an additional hour. For electron microscopy, mice
were prepared as above, only they were perfused with 2% formal-
dehyde and 2% gluteraldehyde in 0.15 M sodium cacodylate. For
anti-carbohydrate staining, sections were blocked in Tris-buffered
saline (TBS; pH 7.4) in 3 mg/ml bovine serum albumin (BSA). CT2
antibody (5 mg/ml) was precomplexed with goat anti-mouse IgM-
FITC (2.5 mg/ml) for 1 h, then added with 50 nM rhodamine-a-
bungarotoxin. All other antibodies were added at 1 mg/ml. Anti-
peptide antibodies were added at 2 mg/ml in TBS with 3 mg/ml
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61Overexpression of the CT GalNAc Transferasegoat anti-rabbit-FITC and 50 nM rhodamine-a-bungarotoxin. Anti-
peptide antibody specificity was confirmed by blocking with excess
peptide. Slides were dried and mounted in glycerol with paraphe-
nylenediamine to prevent quenching. For routine immunofluores-
cence and color staining, slides were analyzed using a Nikon E800
epifluorescence microscope.
Transgenic Mice
The mouse CT GalNAc transferase cDNA containing a FLAG
epitope tag at its N-terminus (Parkhomovskiy et al., 2000) was
subcloned into pBS-HSAvpA (Muscat and Kedes, 1987) at the PacI
site. pBS-HSAvpA is a plasmid that contains a portion of the
human skeletal alpha actin promoter with intronic sequences, an
SV40 splice acceptor site, and SV40 polyadenylation sequences.
After purification by double banding on cesium chloride gradients,
the plasmid was linearized by cutting with KpnI and PvuI, sepa-
rated by agarose gel electrophoresis, and purified using Quiex II
resin (Qiagen). DNA was diluted and injected into fertilized oo-
cytes of CB6 mice by the UCSD Cancer Center Mouse Core
Facility.
Eight lines of transgenic mice were made and analyzed. Geno-
typing was done by RT-PCR and confirmed by Southern blotting
and Western blotting (Fig. 1). Of the eight lines made, two did not
breed, two had low or uneven levels of expression, and four had
high and uniform levels of expression in all skeletal muscles and no
expression in other organs. Three of these lines, 2124 (Tg1), 2159
(Tg2), and 2162 (Tg3), were used in this study. All phenotypes
reported and all molecular analyses shown were found to be present
in multiple lines. Because of their small size, transgenic mice had
difficulty mating. Therefore, several lines were maintained by
transplant of transgenic ovaries into surrogate mothers.
Immunoblotting
Whole cell lysates of skeletal muscle were solubilized by homog-
enization in 75 mM Tris, pH 6.8, 4% SDS, 4 M urea, 20% glycerol,
and 1% b-mercaptoethanol. Samples were diluted and protein
levels were quantitated using Bio-Rad DC protein assay kit (Bio-
Rad, Richmond, CA). Proteins were separated on either 6% or 12%
SDS–PAGE and transferred to nitrocellulose. For anti-carbohydrate
blotting, blots were blocked in Tris-buffered saline (pH 7.4) with
0.1% Tween 20 and 3 mg/ml BSA. Blots were incubated with
anti-CT2 antibody, washed in TBST, incubated in anti-mouse
IgM-alkaline phosphatase, washed, and developed. For all other
antibodies except IIH6 and VIN4-1, blots were blocked in TBST
with 5% nonfat dry milk and secondary antibodies were conjugated
to peroxidase and developed using ECL chemiluminescence. IIH6
and VIN4-1 were used as previously described (Ervasti and Camp-
bell, 1991).
Electron Microscopy
Fixed muscles were postfixed with 2% OsO4, dehydrated, and
embedded. Thin sections (80 nm) were cut using a diamond knife
(Diatome) and an Ultracut E ultramicrotome (Leica) and mounted
on uncoated copper grids. Thin sections were imaged at 80 keV
using a 1200 EX electron microscope (JEOL).
Confocal Microscopy
Fixed muscle was permeabilized in a solution containing 0.1%Triton X-100, 1% normal goat serum, and 1% cold water fish
© 2002 Elsevier Science. Agelatin (Sigma) in PBS for 30 min before incubation in anti-
synaptophysin or anti-neuron-specific enolase for 18 h at 4°C.
Tissue was then washed in buffer and incubated in donkey anti-
mouse IgG-FITC conjugate or donkey anti-rabbit Cyan-conjugate
mixed with 50 nM rhodamine-a-bungarotoxin in PBS for 1 h at 4°C.
Muscles were rinsed in PBS and mounted in Gelvatol. Confocal
microscopy was performed using an MRC-1024 system (Bio-Rad)
attached to an Axiovert 35M (Zeiss AG) using a 340 1.3 n.a.
objective. Individual images (1024 3 1024 pixels) were converted to
PICT format and merged as pseudocolor RGB images using Adobe
Photoshop (Adobe Systems).
Primary Muscle Cultures
Gastrocnemius muscles from 7-week-old wild type and trans-
genic mice were dissected, minced, and digested for 30 min at
37°C, 5% CO2 in dissociation medium containing 2% fetal calf
serum, 1.0 mg/ml collagenase (Sigma), 1.5 mg/ml trypsin (Irvine
Scientific), and 2 mg/ml DNAseI (Boehringer Mannheim) in
DMEM. The now-dissociated muscle tissue was then titurated 20
to 30 times, spun for 5 min at 1500g, and resuspended in primary
culture media containing 20% fetal calf serum, 4% chick embryo
extract (Gibco/BRL), 50 U/ml penicillin, and 50 mg/ml streptomy-
cin in Ham’s F12 media supplemented with glutamine. Cells were
preplated on plastic for 20 min to remove fibroblasts. The media
was removed and cells were titurated again before plating cells on
0.4% gelatin-coated plastic dishes. For myotube fusion assays, cells
were cultured at high density and allowed to grow to confluence,
after which they were induced to fuse into myotubes by placement
in serum-poor media (DMEM with 2% horse serum, 50 U/ml
penicillin, and 50 mg/ml streptomycin) for 3 days. Cells were then
washed and fixed in 2% paraformaldehyde, and myotube fusion
was quantitated by light microscopy by counting random 320
fields of view. To quantitate growth rate, cells were cultured at
lower density and kept in growth media. Cells were counted using
a hemocytometer during passaging at Days 0, 3, and 6.
Analysis of Muscles and Neuromuscular Junctions
Quantitation of central nuclei, myofiber diameter and variance,
and nuclei/myotubes was done using hemotoxylin and eosin stain-
ing of frozen sections using Sigma premade reagents according to
the manufacturer’s instructions. Data for gastrocnemius and ex-
tensor digitorum longus muscles were pooled for statistics, but did
not vary significantly from one another. The coefficient of variance
(standard deviation of diameter 3 1000/mean diameter) was always
below the 250 value expected of normal muscle. Similar results
were also seen for diaphragm. Reductions of at least 60% in
myofiber diameter were seen for all three lines; however, Tg2162
was reduced by 70% and this was significantly more than the
reduction measured for Tg2159 or Tg2124 (P , 0.001). Fiber typing
was done by performing myosin ATPase staining at pH 4.6 (Ha-
malainen and Pette, 1993) on fresh frozen sections. While type 1
fiber levels were increased in the gastrocnemius, the level of
increase was uneven and paralleled the medial–lateral variations in
fiber type reported in Frey et al. (2000). An example of the most
extreme concentration of type 1 fibers is shown in Fig. 2. The
length of the diaphragm and endplate band and number of myofi-
bers with multiple presynaptic specializations were analyzed using
whole-mount stains in which postsynaptic areas were visualized
with rhodamine-a-bungarotoxin. The percentage of satellite cells,
length of I- and A-bands, length of neuromuscular junction, num-
ll rights reserved.
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with invading Schwann cell were analyzed by electron microscopy
(n 5 84 synapses). Satellite cells were determined by the presence
of heterochromatin in the cell nucleus (Bischoff, 1994). While some
increase in satellite cells could be due to changes in fiber type,
given that type I fibers have more satellite cells than type 2 fibers
(Bischoff, 1994), we estimate that this at most could account for
10% of the increase in satellite cell number. Active zones were
defined by increased electron density in the cytoskeleton immedi-
ately next to the presynaptic membrane. In addition, at least two
vesicles had to be within 10 nm of this density and two additional
vesicles had to be immediately behind the two docked vesicles. For
NMJs to be counted as having an invading Schwann cell, a
Schwann cell process had to interdigitate between the nerve
terminal and the myofiber membrane for at least 200 nm. A split
myofibril was defined as one shifted by at least 200 nm relative to
its immediate neighbor. Analysis of significance was done using
the Student’s paired t test in all instances.
Immunoprecipitations
Leg or arm muscles were dissected from wild type or CT
transgenic mice and solubilized in TBS (pH 7.4) with 1% NP-40, 5
mM EDTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF,
1 mM benzamidine, 10 mg/ml pepstatin, and 5 mg/ml bestatin.
Muscles were incubated overnight with shaking at 4°C, and solu-
bilized proteins were assayed for protein concentration as described
earlier. Identical amounts of protein (150 mg/tube) were incubated
with an antiserum made against a/b-dystroglycan (OR12) or a
monoclonal antibody (CT1) made against the CT antigen overnight
at 4°C. Antibodies were added at 10 mg/ml. Secondary controls
were also incubated overnight without primary antibody.
Protein-G agarose (10 ml; OR12) or anti-mouse IgM agarose (CT1)
was added to precipitate primary antibody-bound complexes. After
a 2-h incubation, pellets were washed several times in a large
excess of extraction buffer, removed, and boiled in SDS sample
buffer. Precipitated proteins were then analyzed by Western blot-
ting.
For lectin precipitations, 20 ml of WFA-conjugated agarose was
incubated with 150 mg of protein extract from wild type (Wt) or
transgenic (CT) muscle overnight at 4°C. Identical samples were
also incubated with resins in the presence of 0.3 M GalNAc to
verify specificity of binding. Pellets were spun and washed twice
for 15 min in a large excess of solubilization buffer, and pellets were
boiled in SDS sample buffer and analyzed as above.
evidence of central nuclei (dark spots). (B) Several small regions of
Tg gastrocnemius muscle had increased numbers Type 1 or slow
twitch (black staining) myofibers. (C) c-met, a marker for quiescent
satellite cells, was expressed in many cells in Tg mice. (D) A large
increase in satellite cells (arrows) occurred in Tg mice. Many, but
not all, of these cells were outside the basal lamina of the skeletal
myofibers and were often near blood vessels. A myofiber cell
nucleus is shown below the arrows for comparison. (E) Myofibril
structure in Tg mice was relatively normal, though the I-band was
lengthened and alterations in myofibril spacing were observed
(arrow). Bar is 25 mm in A, 12.5 mm in B, 50 mm in C, 2 mm in D,FIG. 2. Characterization of skeletal muscles in CT transgenic
mice. Sections of gastrocnemius muscle were analyzed in wild type
(Wt) and transgenic (Tg) mice by hematoxylin and eosin staining
(A), myosin ATPase staining (pH 4.6) (B), immunofluorescence (C),
or electron microscopy (D, E). (A) Myofiber diameters were severelyand 0.5 mm in E.
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Using affinity-purified anti-peptide antibodies made
against regions of the CT GalNAc transferase, we first
demonstrated that this enzyme, like the carbohydrate
antigens it creates (Martin et al., 1999), is localized to
the neuromuscular junction (Fig. 1). Expression of the
CT GalNAc transferase was highly colocalized with
rhodamine-a-bungarotoxin staining, which identifies the
high density of acetylcholine receptors present in the
postsynaptic membrane at the neuromuscular junction. In
addition, occasional staining was seen in small blood ves-
sels and capillaries (data not shown), although no extrasyn-
aptic expression was observed in myofibers. Thus, the
expression of the synaptic CT carbohydrate antigen in
skeletal muscle is likely due to the synaptic localization of
the CT GalNAc transferase, which is the enzyme that
creates the synaptic b1,4GalNAc linkage (Smith and Lowe,
1994).
To ascertain potential roles for the CT GalNAc trans-
ferase in synaptic development, we created transgenic (CT)
mice that would maintain extrasynaptic expression of the
CT GalNAc transferase in the skeletal muscles of adult
animals. We characterized three transgenic lines, all of
which expressed the enzyme at high levels in all skeletal
muscles examined and did not express in other tissues (Fig.
1A). This was done by driving CT GalNAc transferase
expression using the human skeletal a actin promoter.
Increased expression of the CT GalNAc transferase was
seen in most muscles by immunostaining (Figs. 1C and 1D)
and all myofibers expressed the CT antigen in relatively
even amounts (Figs. 1E and 1F). Intracellular aggregates of
CT staining could also be seen in some transgenic muscles
(Fig. 1F). While it is impossible to identify all of the
CT-containing glycoproteins using blotting techniques, we
identified several glycoprotein bands that immunoblotted
in wild type muscle extracts with the anti-CT2 monoclonal
antibody (Fig. 1G). Given the low expression of the CT
GalNAc transferase in muscle and its presence in non-
muscle structures such as blood vessels, it was possible that
these were in fact not muscle-specific glycoproteins, de-
spite the use of a muscle protein extract. Therefore, we
repeated this analysis on three lines of transgenic mice
made to overexpress the CT GalNAc transferase specifi-
cally in skeletal muscles, with the hope that newly glyco-
sylated bands would in fact be derived from the glycosyla-
tion of muscle proteins. Several new CT-positive protein
bands were observed in whole muscle lysates from all three
transgenic lines (Fig. 1G). Bands at 35, 85, and 160 kDa
appeared to be increased, though there were clearly others
as well. Similar results were seen with both the CT1 and
the CT2 antibody, both of which can be created by the CT
GalNAc transferase (Smith and Lowe, 1994). These experi-
ments demonstrate that transgenic mice maintained extra-
synaptic expression of the normally synaptic CT antigen
and that CT overexpression altered the glycosylation of
several muscle glycoproteins.
© 2002 Elsevier Science. ACT transgenic mice walked, fed normally, and lived a
normal lifespan. The immediately obvious phenotype of the
transgenic mice was their small size (Fig. 1). Adult mice
were reduced in weight by 40% compared to age- and
sex-matched littermates (Table 1). Analysis of cross sec-
tions of the gastrocnemius, extensor digitorum longus,
intercostal, and diaphragm muscles demonstrated that
myofiber diameters were reduced by 60% at 6 weeks of age
(Fig. 2 and Table 1). This reduction in myofiber diameter
was not caused by a simple developmental delay, as 18-
month-old transgenic mice still had a 40 6 1% reduction in
myofiber diameter (for gastrocnemius, P , 0.001). Only a
7 6 1% decrease in relative myofiber diameter was seen at
birth, while a 41 6 4% change was evident by postnatal day
14 (for gastrocnemius, P , 0.001 for both ages). Thus, most
of the loss in myofiber diameter occurred in the early
postnatal period and persisted well into adulthood. Similar
reductions in diameter were also observed in other muscles,
including the trapezius, gluteus, tricep, quadricep, and
tibialis anterior (data not shown).
While the muscles from the CT transgenic mice were
small, this was not due to a failure of muscle formation or
degeneration. All major muscle groups were present. The
total number of myofibers per muscle was unchanged, as
was the percentage of cells with central nuclei (Table 1). No
significant change in the variability of fiber diameter was
seen (Table 1). The number of nuclei in total cross sections
of the gastrocnemius muscle remained constant (Table 1).
Thus, no significant differences in cell death, degeneration,
or regeneration were apparent in transgenic muscles com-
pared to normal animals. Transgenic muscles were more
rounded and the percentage of type 1 (or slow) fibers was
increased in small regions of the gastrocnemius muscle (Fig.
2, Table 1). However, fiber typing of other muscles, includ-
ing the diaphragm (Table 1), showed no change in fiber type
composition. Muscle ultrastructure was assessed by elec-
tron microscopy of longitudinal sections. All filament
structures appeared normal, with two exceptions. First, the
I-band length was increased in transgenic mice. This could
be an artifact of fixation; however, the muscles were all
stretched prior to fixation and the lengthening was observed
in multiple animals. Thus, it is possible that some aspect of
myofibril structure was altered. The second finding was an
increase in the number of split myofibrils (Fig. 2, Table 1).
This is analogous to what is observed in mice lacking desmin
(Lin et al., 1997), an intermediate filament protein that may
help connect myofibril units (Patel and Lieber, 1997).
The reduced myofiber growth in CT transgenic mice was
due in part to the arrest of satellite cell fusion with
myotubes. During late embryonic and early postnatal de-
velopment, satellite cells associate and often fuse with
already formed myofibers. In doing so, such cells contribute
to the dramatic growth of myofibers that occurs in the early
postnatal period (Bischoff, 1994; Seale et al., 2000). At birth,
approximately 32% of the nuclei in a muscle section are
satellite cells, while in adults less than 5% remain and
serve as a reservoir of regenerative material (Albrook et al.,
ll rights reserved.
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hammer, 1977). In CT transgenic mice, we estimated that
almost 50% of the nuclei outside of myofibers were satel-
lite cells. This was based on the observation of heterochro-
matin in mononucleated cells using electron microscopy.
We admit that this definition is hardly adequate; neverthe-
less, it was trivial to identify transgenic muscles blindly
using this criterion, and the change was quite striking.
Expression of c-met, a marker for quiescent satellite cells,
was dramatically increased in cells surrounding myofibers
in transgenic mice, and electron micrographs showed many
satellite cells present both within and outside the basal
lamina surrounding myofibers (Fig. 2). The reduction in
myofiber diameter was similar to that seen in mice lacking
Pax7, a transcription factor required for the production of
myogenic satellite cells (Seale et al., 2000).
To test further the idea that CT expression caused an
increase in satellite cells or an arrest in their fusion into
myotubes, we extracted satellite cells from muscles of adult
transgenic and wild type mice (Figs. 3A and 3B). Satellite
cells were made using standard techniques with preplating
on tissue culture plastic to reduce intramuscular fibro-
TABLE 1
Alterations in Synaptic and Myofiber Parameters Resulting from C
Parameter Muscles
Weight (Male)
Weight (Female)
Tibia length
% Central nuclei G, EDL
Myofiber diameter G, EDL
Coeff. of diameter variance G, EDL
Myofiber length D
I-band length D, I
A-band length D, I
% Type 1 fibers G
% Type 1 fibers D
% Split myofibrils G, D, I
Nuclei/myotube G
% Satellite cell nuclei G
NMJ length G
NMJ length D
% NMJ with invading SC G
Area of endplate band D
Active zones/NMJ G
Active zones/NMJ D
Secondary folds/NMJ G
Secondary folds/NMJ D
% Myofibers with multiple
presynaptic specializations
G
Note. Measures of myofiber and neuromuscular characteristics
gastrocnemius; D, diaphgram; EDL, extensor digitorum longus; I, i
standard errors of the mean.
* P , 0.05, **P , 0.01, ***P , 0.001, NS, not significant.blasts. Based on c-met staining of plated cells done imme-
© 2002 Elsevier Science. Adiately after extraction, this produced an average of 95%
satellite cells. We counted the number of cells extracted
from wild type and transgenic animals, normalized to the
weight of muscle tissue used for extraction, and then
cultured them using rich media optimized for growth of
satellite cells in culture. At 3 and 6 days, we then recounted
cells to determine relative growth rates (Fig. 3A). Immedi-
ately after plating, there was an 8.5-fold increase (P , 0.02)
in the number of satellite cells extracted from CT trans-
genic mice compared to that from wild type animals. This
degree of increase was similar to the increase in satellite
cells seen in vivo using electron microscopy (Table 1).
Satellite cells taken from wild type mice grew rapidly, as
expected of satellite cells in culture. Wild type cells dis-
played a linear growth rate (R 5 0.97) and had a doubling
time of about once per day.
Cells taken from CT transgenic muscles, by contrast,
showed a negative linear growth rate (R 5 0.99), with about
half of the cells dying by 6 days. We can think of three
scenarios to explain these data. First, CT expression could
cause a developmental defect in satellite cell growth. Sec-
ond, CT expression could be toxic to satellite cells in
ntigen Overexpression in Skeletal Muscle
ild Type Transgenic P value
6 0.6 g 14 6 0.6 g ***
6 0.6 g 14 6 0.2 g **
6 0.4 mm 15 6 0.4 mm NS
6 0.4 3.7 6 1 NS
6 0.4 mm 12 6 0.2 mm ***
160 188 NS
6 0.1 mm 4.2 6 0.2 mm ***
6 40 nm 820 6 40 nm ***
6 0.1 mm 1.3 6 0.1 mm NS
6 1 18 6 3 **
6 1 18 6 1 NS
6 2 20 6 3 ***
6 0.1 1.2 6 0.1 NS
6 2 48 6 5 ***
6 0.7 mm 1.6 6 0.1 mm **
6 0.8 mm 4.4 6 0.6 mm **
6 0 70 6 6 ***
6 20 mm 1,400 6 60 mm ***
6 1 3 6 1 *
6 1 5 6 1 ***
6 1 5 6 1 ***
6 2 4 6 2 ***
6 10 54 6 8 *
compared in 7-week-old wild type and CT transgenic mice. G,
ostal; SC, Schwann cell; NMJ, neuromuscular junction. Errors areT A
W
24
21
15
2.9
29
3.4
380
1.3
6
18
3
1.2
2
4.8
7.6
0
450
6
11
15
21
10
are
ntercculture; or third, satellite cells could be at such a high
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65Overexpression of the CT GalNAc Transferasedensity prior to extraction that they have already differen-
tiated to some extent and have consequently dropped out of
the cell cycle. We tend to favor the third scenario, as
satellite cells in the adult animal were densely packed and
likely contacted each other (e.g., see Fig. 2D). To test
whether satellite cells were competent to fuse into myo-
tubes, we cultured satellite cells from the gastrocnemius
muscle of CT transgenic and wild type mice at high density
(Fig. 3B). When induced to fuse by growth in serum-poor
media, transgenic cells formed myotubes at levels similar
FIG. 3. Analysis of satellite cell growth and fusion in culture.
Muscles from wild type (Wt) and CT transgenic mice (CT) were
dissected and primary cultures of satellite cells were grown in
culture. (A) Upon initial culturing, there was an 8.5-fold increase in
the number of satellite cells per weight of dissected muscle taken
from transgenic mice compared to that from wild type mice (P ,
0.02). Satellite cells from wild type mice grew at a linear rate (R 5
0.97) over the course of 6 days, multiplying roughly every day. By
contrast, satellite cells from CT mice did not grow and decreased in
number linearly over the course of 6 days (R 5 0.99). (B) Satellite
cells from wild type (Wt) and CT transgenic mice (CT) were
cultured at high density. Cells were induced to fuse into myotubes
by placement in serum-poor media for 3 days. The number of
myotubes per random 320 field of view was counted. Wt and CT
cells fused equally well (P 5 0.2).to those seen with wild type cells (P 5 0.2). Therefore, the
© 2002 Elsevier Science. Afailure of postnatal muscle growth in CT transgenic mice
was not due to a general inability of satellite cells to form
myotubes.
Neuromuscular junctions of CT transgenic mice dis-
played abnormal structure by a number of measures (Fig. 4,
Table 1). First, the size of individual junctions was reduced,
as would be expected given the smaller size of the myofi-
bers. This was apparent both by electron (Figs. 4C and 4D)
and confocal (Figs. 4E and 4F) microscopy. The length of
neuromuscular junctions was reduced by 67 6 7% in the
gastrocnemius muscle and by 43 6 5% in the diaphragm
(P , 0.01 for both). Secondary folds in the muscle mem-
brane were reduced and in some cases were completely
absent. Electron micrographs of transgenic muscles (Figs.
4D and 4G) showed that secondary folds were not only
reduced but were often not aligned with active zones and
sometimes not even with the nerve terminal (Fig. 4D).
Some synapses appeared more normal, however; overall,
there was a 55 6 8% reduction in folds in the gastrocne-
mius (P , 0.001) and a 67 6 9% reduction in folds in the
diaphragm (P , 0.001). The width of the synaptic cleft was
normal, but Schwann cells that normally cap the nerve
terminal often extended processes between the nerve and
muscle. Fully two thirds of transgenic neuromuscular junc-
tions examined had some Schwann cell process between
their nerve terminal and the postsynaptic membrane (Table
1). Nerve terminals had active zones (though reduced in
number; Table 1) with docked secretory vesicles and had
normal vesicle distribution, with most secretory vesicles
being present on the half of the nerve terminal closest to the
myofiber. In addition, colabeling of postsynaptic mem-
brane, motor axons, and nerve terminals was done to
further characterize neuromuscular development (Figs. 4E,
4F, 4H, and 4I). Several differences were observed. First,
individual synapses had disjointed expression of acetylcho-
line receptors (AChRs) that lacked the contiguous pretzel-
like pattern of normal junctions (Figs. 4E and 4F). Second,
the innervation pattern of the muscle was fundamentally
different. In many muscles, including diaphragm and inter-
costal muscles, axons migrate in a direction perpendicular
to that of their target myofibers. This creates an “endplate
band” of innervation near the middle muscle. In CT trans-
genic mice, the distance over which innervation occurred
tripled (Fig. 4B and Table 1), and axons sometimes sprouted
and migrated beyond neuromuscular junctions (Figs. 4H
and 4I). Third, many myofibers had more than one presyn-
aptic specialization (Figs. 4H and 4I). This contrasts with
the one synapse per muscle situation found at most adult
neuromuscular junctions (see Sanes and Lichtman, 1999).
Given the large changes observed in neuromuscular
structure, we were interested to determine whether any of
the molecules implicated in neuromuscular development
by genetic studies would have altered protein expression
patterns in the CT transgenic mice. Two nerve-derived
proteins, agrin and ARIA, have been shown to be important
for the organization of the postsynaptic membrane. Mice
lacking neural agrin fail to properly localize acetylcholine
ll rights reserved.
66 Xia et al.receptors under the nerve during development (Gautum et
al., 1996; Burgess et al., 1999), and mice that are heterozy-
gous for a form of ARIA have a 50% reduction in acetyl-
choline receptor mRNA levels (Sandrock et al., 1997).
Likewise, several muscle-derived synaptic chains of lami-
FIG. 4. Characterization of neuromuscular innervation in CT tran
with rhodamine-a-bungarotoxin to label acetylcholine receptors (
microscopy (C, D, G, J) or confocal microscopy (E, F, H, I), w
(synaptophysin, green) and postsynaptic membrane (acetylcholine
greatly expanded in Tg mice (B) compared to control animals (A
indicated by arrows in C), while Tg muscles had few and sometimes
were often present on Tg muscles (D, J) and multiple synapses w
junctions displayed the typical pretzel-shaped pattern of postsyn
membranes (F) and displayed abnormal axonal migration (arrows in
but secondary folds were very reduced and processes from Schwann
the synaptic cleft. Bar in A is 500 mm (for A, B), 7.5 mm (for E, F), a
in J.nin, in particular laminin b2 and laminin a4, have impor-
© 2002 Elsevier Science. Atant roles in presynaptic development. Mice lacking lami-
nin b2 have deficits in active zone and secondary fold
formation as well as Schwann cell invasion into the synap-
tic cleft (Noakes et al., 1995; Patton et al., 1998). Mice
lacking laminin a4 have normal numbers of active zones
ic mice. Diaphragm muscle was analyzed by whole-mount staining
, or sections of gastrocnemius muscle were analyzed by electron
axons (neuron-specific enolase, blue in E, F), nerve terminals
tors, red) were colabeled. The endplate band of the diaphragm was
ividual NMJs in Wt mice had numerous secondary folds (some
condary folds (D). In addition, multiple presynaptic specializations
resent on the same muscle (numbers in H, I). Wt neuromuscular
membrane (E), while Tg junctions had disjointed postsynaptic
). Active zones were still present at Tg synapses (arrowheads in G),
(arrow in G), often extended between the nerve and muscle within
mm (for H, I). Bar is 0.5 mm in C (for C, D), 0.2 mm in G, and 1 mmsgen
A, B)
here
recep
). Ind
no se
ere p
aptic
H, I
cells
nd 5and secondary folds, but do not properly organize them
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67Overexpression of the CT GalNAc Transferaseacross the synaptic cleft (Patton et al., 2001). Mice lacking
laminin a5 die as embryos (Miner et al., 1998), although cell
culture studies suggest that laminin a5 can alter presynap-
tic development and be responsible for some of the pheno-
types observed in laminin b2-deficient mice (Patton et al.,
1997). Mice lacking a particular laminin chain often replace
it with another isoform (Martin et al., 1996; Patton et al.,
1998); thus, it is often difficult to discriminate whether a
given phenotype is caused by the loss of one chain or the
ectopic expression of another. Mice lacking NCAM have
also been implicated in pre- and postsynaptic development.
Mice overexpressing NCAM in skeletal muscles show
sprouting of Schwann cells and axons (Walsh et al., 2000),
and NCAM-deficient mice have slightly decreased neuro-
muscular size and deficits in paired-pulse facilitation (Mos-
coso et al., 1998; Rafuse et al., 2000). In addition, muscles
lacking dystroglycan have abnormal neuromuscular struc-
tures (Cote et al., 1999). a-Dystroglycan can bind to lami-
nins and agrins, while b-dystroglycan can bind to cytoplas-
mic proteins, including dystrophin and utrophin (for
review, see Henry and Campbell, 1999).
As we had expressed the CT antigen in skeletal muscle,
we focused on the expression of synaptic laminin chains
and their binding proteins (Fig. 5). Laminin a4 and laminin
a5 were expressed around myofibers in transgenic mice, as
was utrophin, a synaptic homolog of dystrophin (Ohlen-
dieck et al., 1991) (Fig. 5). In addition, expression of the cell
adhesion molecule NCAM, a normally synaptic protein
(Couvalt and Sanes, 1986), and the intermediate filament
protein desmin, were increased (Fig. 5). Other molecules
that are normally expressed along extrasynaptic regions of
myofibers, including laminin b1, b-dystroglycan, a-sarco-
glycan, dystrophin (all Fig. 5), and dystrobrevin (not shown),
were unchanged in their expression pattern. Expression of
laminin b2 and acetylcholinesterase, both normally synap-
tic molecules (McMahan et al., 1978; Hunter et al., 1989),
remained synaptic (Fig. 5). Increased protein levels could be
measured for laminin a4, laminin a5, NCAM, and utrophin
(Fig. 6), consistent with their increased expression around
myofibers. Expression of c-met was also increased, consis-
tent with the increase in satellite cells. Several additional
protein bands were evident for desmin and dystrobrevin
(Fig. 6). It is not clear whether these represent proteolytic
products or novel isoforms. For example, the new dystro-
brevin band seen in transgenic extracts migrates at the
expected molecular weight of dystrobrevin 3 and/or 4
(Peters et al., 1998). An additional dystrobrevin band was
also seen in muscle extracts of two of the three CT
transgenic lines at 22 kDa, which would be consistent with
the molecular weight of dystrobrevin 5 (data not shown).
Other developmental events, such as expression of the
epsilon chain of the acetylcholine receptor (Fig. 6), the
elimination of M-cadherin expression along myofibers, and
the concentration of synapsin and SNAP 25 in nerve termi-
nals (data not shown), occurred normally. Thus, ectopic
expression of the CT antigen altered the expression of a
© 2002 Elsevier Science. Agroup of normally synaptic molecules but did not appear to
simply arrest all development.
Given the rather complex group of phenotypes, both
cellular and molecular, in the CT transgenic mice, it was of
interest to begin to identify the glycoproteins that had
increased expression of the CT antigen in transgenic
muscles. In immunoblotting for proteins in extracts of
transgenic muscle, we noticed that very developed immu-
noblots for a-dystroglycan had several proteolytic products
(85 and 35 kDa; Fig. 7) that comigrated with bands identi-
fied by anti-CT antibodies (Fig. 1). To test whether
a-dystroglycan was glycosylated with the CT antigen, we
extracted skeletal muscle tissue from wild type and CT
transgenic muscle using nonionic detergent and subjected it
to precipitation with anti-dystroglycan antisera, anti-CT
antibody, or WFA, a bGalNAc-binding lectin (Fig. 7). Pre-
cipitated proteins were then blotted with antibodies to
dystroglycan or the CT carbohydrate. Two protein bands
(160 and 35 kDa) were precipitated by both CT1 and
dystroglycan antibodies that could be recognized by anti-
bodies to the CT antigen and to a-dystroglycan (Fig. 7A).
These molecular weights correspond to the weight of ma-
ture a-dystroglycan (160 kDa) and a presumed proteolytic
fragment (35 kDa).
Since anti-carbohydrate IgM antibodies are difficult to
use in such experiments, we also precipitated identical
amounts of protein from wild type and transgenic muscle
extracts using WFA, a bGalNAc-specific binding lectin,
conjugated to agarose (Fig. 7B). A significant amount of
mature (160 kDa) a-dystroglycan could be precipitated from
CT muscle, while none was precipitated from wild type
muscle. a-Dystroglycan precipitated from CT muscle was
also recognized by anti-CT antibody. In addition,
b-dystroglycan, which binds tightly to the a-chain (Ervasti
and Campbell, 1991), was also precipitated from CT muscle
using this lectin. Addition of 0.3 M GalNAc during the
precipitation blocked a-dystroglycan binding to WFA, dem-
onstrating that lectin binding was GalNAc specific. No
proteolytic fragments of a-dystroglycan were precipitated
to a significant degree in these experiments. Because the CT
glycans are likely present in the mucin region of the
a-dystroglycan protein, where many copies of these struc-
tures would be highly packed together, the binding of
a-dystroglycan to IgM antibodies and WFA, both of which
are large multivalent binding proteins, is likely to be
complex. Nevertheless, these data strongly suggest that
a-dystroglycan can be glycosylated with the CT antigen in
the skeletal muscles of CT transgenic mice.
DISCUSSION
The results presented suggest four novel roles for the CT
carbohydrate antigen in muscle growth and neuromuscular
development. First, the CT antigen alters the expression of
a group of synaptic proteins, including laminin a4, laminin
a5, utrophin, and NCAM (Figs. 5 and 6). All of these
ll rights reserved.
68 Xia et al.FIG. 5. Extrasynaptic expression of normally synaptic proteins in CT transgenic mice. Cross sections of gastrocnemius muscle in wild
type (Wt) and transgenic (Tg) muscles were stained with antibodies to laminin a2, laminin a4, laminin a5, laminin b2, laminin b1, NCAM,
acetylcholinesterase (AChE), b-dystroglycan, a-sarcoglycan, utrophin, dystrophin, and desmin. Increased extrasynaptic expression of
laminin a4, laminin a5, and utrophin was seen around myofibers in Tg mice, and increased expressions of desmin, both intracellular and
extracellular, and NCAM were seen. Therefore, CT carbohydrate expression caused the ectopic expression of a group of normally synaptic
proteins. Normal expression of laminin a5 in capillaries and blood vessels is shown in Wt as is expression of laminin b2 in blood vessels.
Acetylcholinesterase was expressed only at neuromuscular junctions (examples shown by arrows) in both Tg and Wt animals, while
laminin a2, laminin b1, dystrophin, b-dystroglycan, and a-sarcoglycan, which are normally expressed around myofibers, were unchanged.
NCAM is normally confined to the neuromuscular junction in adult animals (arrow shows NMJ in Wt). Bar is 50 mm for all images.
© 2002 Elsevier Science. All rights reserved.
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69Overexpression of the CT GalNAc Transferaseproteins have effects of their own on neuromuscular struc-
ture or function (Noakes et al., 1995; Patton et al., 1997,
1998, 2001; Moscoso et al., 1998; Rafuse et al., 2000; Walsh
et al., 2000). While we cannot rule out that some of these
proteins are directly glycosylated with the CT antigen,
some of the proteins affected by CT expression do not
appear to comigrate with glycoproteins bearing the carbo-
hydrate (Figs. 1 and 6). Thus, it is likely that at least some
of these proteins are not targeted by direct glycosylation
with the CT carbohydrate. Second, CT expression alters
postnatal myofiber growth (Fig. 2 and Table 1). This appears
to be due in part to a failure of satellite fusion with
preexisting myofibers (Figs. 2 and 3). Satellite cells have
been reported to be concentrated about 20-fold in areas
surrounding the neuromuscular junction (Wokke et al.,
1989). If such an accumulation involves signals from the
synaptic matrix or membrane, the increased extracellular
expression of such signals in the CT transgenic mice may
increase satellite cell numbers in extrasynaptic areas. It is
also possible that the increased expression of synaptic
laminins or NCAM may inhibit satellite cell fusion into
myotubes and, in doing so, increase their number. Third,
the CT carbohydrate alters neuromuscular structure (Fig. 4
and Table 1). The loss of secondary folds in the muscle
FIG. 6. Increased expression of synaptic proteins in CT transgenic
(20 mg) were compared in wild type (Wt) and transgenic (Tg) mice. A
laminin a4 (200 kDa), laminin a5 (;400 kDa), utrophin (;400 kDa
also increased for desmin (53 kDa) and dystrobrevin (90 and 65
lower-molecular-weight bands (;50 kDa for desmin and 44 kDa
kDa), laminin b1 (;220 kDa), and the epsilon chain of the acetylcmembrane, the invasion into the synaptic cleft of the
© 2002 Elsevier Science. ASchwann cell processes, and the misalignment of active
zones and secondary folds are similar to findings in mice
lacking laminin b2 (Noakes et al., 1995; Patton et al., 1998),
laminin a2 (Ellisman, 1981), or laminin a4 (Patton et al.,
2001). Therefore, as CT transgenic mice display altered
expression of several laminin chains, redistribution of lami-
nins a4 and a5 may contribute to these phenotypes. Finally,
the CT carbohydrate alters synaptic topography (Fig. 4). The
pattern of neuromuscular junctions was altered, both on
individual myofibers and on the muscle as a whole. Sprout-
ing of axons is also seen in transgenic mice that overexpress
NCAM (Walsh et al., 2000). As CT transgenic mice also
overexpress NCAM in extrasynaptic regions, NCAM would
appear to be a logical candidate to mediate these pheno-
types.
The finding that a-dystroglycan can be glycosylated with
the CT antigen in muscle cell extracts (Fig. 7) points to a
potential mechanism that would explain the misexpres-
sion of both laminin chains and utrophin, as dystroglycan
binds to these proteins. a-Dystroglycan isolated from
skeletal muscle contains a unique carbohydrate struc-
ture, NeuAca2,3Galb1,4GlcNAcb1,2Mana-O-Ser, on its
mucin domain (Sasaki et al., 1998). The terminal
NeuAca2,3Galb1,4GlcNAc portion of this structure should
e. Western blots of equivalent amounts of total muscle cell protein
nts of total protein were increased for c-met (50 kDa, N-terminal),
NCAM (160–180 kDa) in CT transgenic mice. Protein levels were
), but in both cases this was due to the presence of additional
strobrevin). Levels of dystrophin (;400 kDa), b-dystroglycan (43
e receptor (AChR, ;60 kDa) were unchanged.mic
mou
), and
kDa
for dybe a good substrate for the CT GalNAc transferase (Smith
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70 Xia et al.and Lowe, 1994). a-Dystroglycan can bind extrasynaptic
laminin chains, such as laminin a2 and the embryonically
expressed laminin a1 (Talts et al., 1999), and can bind with
apparently weaker affinity to laminin a4 (Talts et al., 2000).
Its transmembrane binding partner, b-dystroglycan, like-
wise can bind both the extrasynaptic cytoplasmic protein
FIG. 7. Glycosylation of a-dystroglycan with the CT antigen in sk
extract from wild type (Wt) and CT transgenic (CT) showed that s
muscles. Nonionic detergent extracts of skeletal muscle from CT
(CT1) or with an anti-serum against dystroglycan (OR12). Antib
anti-mouse IgM-agarose (for CT1), or extracts were incubated with
Western blotting using antibodies to a-dystroglycan (IIH6) or the C
to a-dystroglycan and the CT antigen when precipitated with eith
for the CT1 precipitation and subsequent immunoblot (asterisk). (B)
were precipitated by WFA agarose, a lectin that binds bGalNAc. W
that could be identified by antibodies to the CT antigen (CT1) and a
experiments that was identified by antibodies to b-dystroglycan
proteins was precipitated from an identical amount of protein extr
be blocked by addition of excess GalNAc (1GalNAc).dystrophin (Ervasti and Campbell, 1991) and its synaptic
© 2002 Elsevier Science. Acounterpart, utrophin (James et al., 2000). In adult animals,
utrophin (Ohlendieck et al., 1991) and laminins a4 and a5
(Patton et al., 1997) are normally present only at the
neuromuscular junction, while a- and b-dystroglycan are
present both at the synapse and in extrasynaptic regions
(Ohlendieck et al., 1991). Therefore, it is highly likely that
al muscles of CT transgenic mice. (A) Immunoblots of muscle cell
l fragments of a-dystroglycan (aDG) were increased in transgenic
genic mice were precipitated with an antibody to the CT antigen
bound complexes were precipitated by Protein-G (for OR12) or
ns alone (control, C). Precipitated proteins were then subjected to
igen (CT1). Bands at 160 and 35 kDa were identified by antibodies
tibody. Secondary antibody alone recognized the IgM heavy chain
ionic detergent extracts of wild type (Wt) or transgenic (CT) muscle
precipitated a 160-kDa mucinlike protein from transgenic muscle
troglycan (VIN4-1). A 43-kDa band was also coprecipitated in these
7), but it did not coblot with anti-CT antibodies. None of these
from wild type muscle. Binding of a-dystroglycan to WFA couldelet
evera
trans
ody-
resi
T ant
er an
Non
FA
-dys
(DG6
actedthere is something about dystroglycan at the neuromuscu-
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71Overexpression of the CT GalNAc Transferaselar junction that defines it as a synaptic form of the protein.
The presence of the synaptic CT glycan on a-dystroglycan
in CT transgenic muscles suggests that the CT antigen is
the synaptic modifier of a-dystroglycan that defines it as a
synaptic protein. As the neuromuscular junction represents
such a small amount of the myofiber membrane, it may not
be possible to identify CT-containing a-dystroglycan in
wild type mice. Indeed, we have not yet been able to do so.
Nevertheless, the presence of CT on a-dystroglycan in CT
transgenic muscle suggests that it is normally present on
a-dystroglycan at the synapse, and that this may give it
unique properties in binding to or localizing synaptic lami-
nins and utrophin. Overexpression of “synaptic” dystrogly-
can in CT transgenic mice would then allow expression of
utrophin and laminins a4 and a5 along myofibers where
this normally would not occur.
While the molecular mechanism for the developmental
effects shown here has yet to be determined, the dramatic
alterations in muscle growth and neuromuscular structure
exhibited by animals overexpressing the CT antigen sug-
gests that it is important for neuromuscular development.
We are hopeful that similar transgenic approaches may be
used to identify functions for other synaptic glycans where
no function has been described in vivo. The CT antigen, for
example, is also expressed on the presynaptic membrane at
the neuromuscular junction (Martin et al., 1999), and no
function has yet been described for it there. Likewise,
terminal b3-linked GalNAc structures, including globoside
(Martin et al., 1999) and GalNAc phosphate structures
(Scott et al., 1999), appear to be expressed at the mamma-
lian neuromuscular junction. Therefore, other synaptic
GalNAc forms may be present on other proteins and orga-
nize different developmental events. Finally, high mannose
structures are localized at excitatory synapses in the brain
(Matus et al., 1973; Gurd and Fu, 1982; Clark et al., 1998),
and transgenic approaches may be useful in elucidating
their role in synapse formation as well.
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